NRXPW
NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. (NRXPW) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 55.0, with 1/3 trend checks passing.
NRXPW with MA50 and MA200
Key levels & signals
NRXPW valuation multiples (TTM)
NRXPW analyst consensus
NRx Pharmaceuticals, Inc. (NRXPW) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $0.01, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 21.1% and below the 200-day moving average by 76.9%.
NRXPW currently has an RSI reading of 55.0, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.
This page is designed to help you quickly understand what the NRXPW chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development of novel therapies for central nervous system ailments and life-threatening lung conditions. Its portfolio includes ZYESAMI, an investigational medicine that has progressed through Phase IIb/III clinical trials for severe respiratory distress linked to COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, orally administered treatments engineered to address bipolar depression in individuals exhibiting both acute and sub-acute suicidal ideation and actions. This Delaware-based company, located in Wilmington, was established in 2015.
NRXPW shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about NRXPW
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.